Medifast Q2

Medifast, the company behind OPTAVIA®, reported revenue of $220.0 million for the second quarter ended June 30, 2020. Second quarter revenue increased 17.6% to $220.0 million from revenue of $187.1 million for the second quarter of 2019. OPTAVIA-branded products represented 83 percent of consumable units sold for the second quarter compared to 75 percent for the same period a year ago.…

Read More

Medifast recently hosted a new live broadcast event experience, OPTAVIA Together Live, replacing its traditional in-person convention, which was cancelled due to the global pandemic. The international event, streamed July 24–26, attracted more than 50,000 registrants from across the globe. The presentations generated more than 140,000 views on Facebook, as Coaches hosted watch parties and live events on…

Read More

Medifast, Inc. announced that it has appointed James (Jim) Maloney as chief financial officer, effective today. In his role, Maloney will be responsible for leading the finance function, including all aspects of financial planning and analysis, setting Medifast’s financial and capital allocation strategies and managing investor relations. He will serve as a member of the…

Read More

Nearly nine out of ten U.S. adults (88%) report experiencing stress during the pandemic, according to a survey conducted by Medifast. Additionally, 82 percent of those surveyed are concerned about at least one aspect of their physical or mental health, and one-fifth are struggling to make progress on their pre-pandemic health goals. Medifast, the company behind OPTAVIA®, surveyed…

Read More

Medifast (NYSE: MED), the company behind the health and wellness community OPTAVIA®, reported results for the first quarter ended March 31, 2020. First quarter revenue increased 7.6 percent to $178.5 million from revenue of $165.9 million for the first quarter of 2019. OPTAVIA-branded products represented 79 percent of consumable units sold for the first quarter compared to 73 percent for the same period…

Read More

Medifast, Inc. announced that Timothy G. Robinson, chief financial officer, will be stepping down from his position at the company on March 31, 2020. Medifast Chief Executive Officer Dan Chard and the Board of Directors have retained a leading international executive search firm to help the company identify and appoint a long-term successor to Robinson. Joseph Kelleman has…

Read More

Medifast (NYSE: MED) yesterday reported revenue increased 17 percent in the fourth quarter and 42.4 percent for the full year ended December 31, 2019. Fourth quarter revenue increased to $170.6 million from revenue of $145.8 million for the fourth quarter of 2018. OPTAVIA-branded products represented 79 percent of consumable units sold for the fourth quarter compared…

Read More

Medifast announced it will ring The Opening Bell® at the New York Stock Exchange (NYSE) on March 2, 2020, in celebration of its strong 2019. To honor the occasion, Medifast Chief Executive Officer Dan Chard will be joined by Mike MacDonald, chairman of the Board, Dr. Wayne Scott Andersen, co-founder of OPTAVIA and Independent OPTAVIA Coach, members of the executive team and other…

Read More
Medifast Q1 2019

Medifast, the company behind, OPTAVIA, was recently featured on Tamron Hall. Independent OPTAVIA Coach couple Christina and Jorge Gutierrez shared their story with Tamron and her 1.3 million viewers in New York City. The Gutierrez’s started with OPTAVIA in 2018 after a tumultuous year. In November 2017, the couple’s daughter was diagnosed with autism, which naturally triggered a period of marital stress. Coupled…

Read More
Medifast Opens in Singapore

Medifast, the company behind OPTAVIA, announced its official opening in Singapore. To celebrate, the company hosted several events starting on December 6, including a ribbon-cutting ceremony and a public event at the Kallang Wave Mall. “Expanding the OPTAVIA movement to Singapore enables us to bring our revolutionary approach to health and wellness to those in…

Read More